论文信息 - Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

OBJECTIVE The aim of this study was to establish an objective and reliable index to predict the development of Alzheimer's disease in a large pool of elderly patients with mild cognitive impairment. METHOD Twenty-three patients with probable Alzheimer's disease, 22 patients with mild cognitive impairment who eventually developed Alzheimer's disease, eight patients with mild cognitive impairment who did not develop dementia, and 19 cognitively normal subjects were included in the study. The authors constructed a new diagnostic index, the CSF-CBF index, based on CSF tau levels divided by regional cerebral blood flow (CBF) in the posterior cingulate cortex. RESULTS Receiver operating characteristic analysis showed that applying a cutoff value for the CSF-CBF index of 296.0 achieved a sensitivity of 88.5% and a specificity of 90.0% in discriminating mild cognitive impairment that progressed to Alzheimer's disease from mild cognitive impairment that did not progress to Alzheimer's disease. CONCLUSIONS The CSF-CBF index is useful in predicting Alzheimer's disease in subjects with mild cognitive impairment.

[1] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[2] B L Holman,et al. Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.

[3] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[4] C A Roe,et al. Statistical Comparison of Two ROC-curve Estimates Obtained from Partially-paired Datasets , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[5] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[6] H. Arai. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals , 1997 .

[7] Nobuyuki Okamura,et al. CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study , 2000, Experimental Neurology.

[8] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[9] J. Baron,et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. , 1999, Brain : a journal of neurology.